Hematology/ Oncology and Stem Cell Therapy
Open Access
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Aims and Scope
Hematology Oncology and Stem Cell Therapy is an international, peer-reviewed, open access journal that provides a vehicle for publications of high-quality clinical as well as basic science research reports in hematology and oncology. The contents of the journal also emphasize the growing importance of hematopoietic stem cell therapy for treatment of various benign and malignant hematologic disorders and certain solid tumors.The journal prioritizes publication of original research articles but also would give consideration for brief reports, review articles, special communications, and unique case reports. It also offers a special section for clinically relevant images that provide an important educational value. Less
Key Metrics
Journal Specifications
Indexed in the following public directories
Scopus 
SJR
- PublisherElsevier
- LanguageEnglish
- Publication Time27
- Editorial Review ProcessDouble blind peer review
- LanguageEnglish
- Society/Institute/SponsorKing Faisal Specialist Hospital & Research Centre
- Website URL
- Publication Time27
- Editorial Team
- Review ProcessDouble blind peer review
- Review Url
- Author instructions
- License typeCC BY, CC BY-NC-ND
- OA statement
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating Topics Covered on Hematology/ Oncology and Stem Cell Therapy
Year-wise Publication
- 5Y
- 10Y
FAQs
Who is the publisher of Hematology/ Oncology and Stem Cell Therapy? 
The publisher of Hematology/ Oncology and Stem Cell Therapy is Elsevier.
Where can I find a journal's aims and scope of Hematology/ Oncology and Stem Cell Therapy?
For the Hematology/ Oncology and Stem Cell Therapy's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of Hematology/ Oncology and Stem Cell Therapy on editage?
For the Hematology/ Oncology and Stem Cell Therapy metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Hematology/ Oncology and Stem Cell Therapy?
The eISSN number is 2589-0646 and pISSN number is 1658-3876 for Hematology/ Oncology and Stem Cell Therapy.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object], [object Object].
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.